GHK-Cu vs BPC-157

Both are 'repair' peptides — but they operate on completely different tissues and pathways. When each is used, and why they are complementary.

GHK-Cu is a copper-binding tripeptide studied primarily for skin, hair, and extracellular-matrix remodeling. BPC-157 is a 15-amino-acid gastric peptide studied for tendon, gut, and vascular repair. They are not substitutes.

Side-by-side comparison

	GHK-Cu	BPC-157
Class	Copper-binding tripeptide	Pentadecapeptide
Sequence length	3 amino acids + Cu²⁺	15 amino acids
Primary tissue focus	Skin, hair follicle, ECM	Tendon, gut, vasculature
Mechanism highlight	Copper delivery, collagen synthesis	VEGFR2 / nitric-oxide signaling
Typical route	Topical or SC / IM	SC (near injury site)
Common use pairing	Standalone or with BPC-157/TB-500 blend	TB-500 for connective-tissue protocols

About GHK-Cu

GHK-Cu is a naturally occurring tripeptide that binds copper. It has decades of dermatological and regenerative-research literature focused on collagen, wound repair, and follicle biology.

Modulates copper transport and influences gene expression linked to collagen synthesis, antioxidant defense, and tissue remodeling.

• Skin and collagen research
• Hair-follicle studies
• Wound-healing models

About BPC-157

BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It is one of the most extensively studied research peptides in the recovery space, with a deep preclinical literature focused on tendon, ligament, muscle, and gastrointestinal tissue.

Research suggests BPC-157 upregulates growth factor receptors (VEGFR2, FAK-paxillin signaling) and modulates the nitric oxide system, supporting angiogenesis and tissue regeneration in animal models.

• Soft-tissue and tendon recovery research
• Gastrointestinal lining and ulcer-model studies
• Joint and ligament repair research
• Vascular and angiogenic studies

The takeaway

These peptides address different problems. GHK-Cu is the choice for skin and follicular research; BPC-157 is the choice for tendon and gut research. In blends like GLOW they are stacked deliberately.

How to read this comparison

The table above compares published characteristics, not outcomes for any individual. Mechanism, half-life, and dosing cadence are properties of the molecule; response, tolerability, and suitability are properties of the person. Trial averages describe populations and say nothing definitive about a single case.

• Check which compound has approved clinical use for the indication you care about, and which does not.
• Compare half-life and dosing cadence against how consistently a protocol can actually be followed.
• Read both individual reference pages before drawing a conclusion from the table alone.
• Any clinical decision belongs with a licensed practitioner who knows the full history.

Important

All peptide products referenced are intended solely for research, investigational, or licensed professional use. They are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed medical practitioner before any personal or clinical use.

Frequently asked questions

Is GHK-Cu used topically or by injection in research?

Both routes appear in the literature — topical formulations for skin/hair studies and injectable for systemic research models.

What is BPC-157 used for in research?

BPC-157 is studied primarily for soft-tissue healing, tendon and ligament repair, and gastrointestinal protection in animal models.

Is BPC-157 FDA-approved?

No. BPC-157 is not approved by the FDA for any human use and is sold for research, investigational, or licensed professional use only.